[HTML][HTML] Cannabinoids as therapeutic agents in cancer: current status and future implications

B Chakravarti, J Ravi, RK Ganju - Oncotarget, 2014 - ncbi.nlm.nih.gov
The pharmacological importance of cannabinoids has been in study for several years.
Cannabinoids comprise of (a) the active compounds of the Cannabis sativa plant,(b) …

[HTML][HTML] Design and biological evaluation of delivery systems containing bisphosphonates

B Aderibigbe, I Aderibigbe, P Popoola - Pharmaceutics, 2016 - mdpi.com
Bisphosphonates have found application in the treatment of reoccurrence of bone diseases,
breast cancer, etc. They have also been found to exhibit antimicrobial, anticancer and …

A Review on Re-Packaging of Bisphosphonates Using Biomaterials

D Barik, P Dash, PI Uma, S Kumari, M Dash - Journal of Pharmaceutical …, 2021 - Elsevier
The need for bone repair and insight into new regeneration therapies as well as
improvement of existing regeneration routes is constantly increasing as a direct …

Role of ATP-sensitive potassium channels in modulating nociception in rat model of bone cancer pain

H Xia, D Zhang, S Yang, Y Wang, L Xu, J Wu, J Ren… - Brain research, 2014 - Elsevier
Bone cancer pain is a major clinical problem and remains difficult to treat. ATP-sensitive
potassium (K ATP) channels may be involved in regulating nociceptive transmission at the …

Pathogenesis and bisphosphonate treatment of skeletal events and bone pain in metastatic cancer: focus on ibandronate

HB Sittig - Oncology Research and Treatment, 2012 - karger.com
Bone metastases are the most common cause of pain in patients with advanced cancer, and
are associated with progressive skeletal destruction, spinal problems, and hypercalcaemia …

[PDF][PDF] Severe Refractory Hypocalcemia Caused by Denosumab

S Dadana, S Gundepalli, A Kondapalli - Cureus, 2023 - cureus.com
Denosumab is a fully human monoclonal antibody that binds to the receptor activator of
nuclear factor kappa-Β ligand, an essential cytokine factor in bone resorption, which reduces …

Adjuvant Therapies in Metastatic Bone Disease

R Yechieli, S Bialick, C Seldon, E Jonczak - Operative techniques in …, 2021 - Elsevier
Bone is a common site of metastatic disease in both solid tumor and hematologic
malignancies. Skeletal involvement of cancer and the complications from these metastases …

Severe Refractory Hypocalcemia Caused by Denosumab

D Sriharsha, G Sai, K Anusha - Cureus, 2023 - search.proquest.com
Denosumab is a fully human monoclonal antibody that binds to the receptor activator of
nuclear factor kappa-Β ligand, an essential cytokine factor in bone resorption, which reduces …

Management of Metastatic Bone Pain in a Patient with Advanced Breast Cancer: The Advanced Practice Nurse's Perspective.

YU Xia - Singapore Nursing Journal, 2017 - search.ebscohost.com
Metastatic bone pain can be very severe and disabling. Effective management requires a
multi-modal multidisciplinary approach. Rennie (pseudonym), a 58-year-old lady was …

Palliative Treatments for the Sacrum

AF Mavrogenis, GN Panagopoulos, A Angelini… - Tumors of the Sacrum …, 2017 - Springer
A wide array of tumors can occur in the sacrum. Benign tumors include giant cell tumors
(60%), aneurysmal bone cysts (4%), and osteoblastomas [1]. Malignant tumors of the …